For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Ovarian Screening | Participants undergo blood sample collection for CA125 analysis at baseline annually for 5 years. Participants also undergo an OVR (discontinued in December 1998) and TVU at baseline and annually for 3 years. | None | None | 0 | 34253 | 903 | 34253 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anxiety | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Bruising | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Bleeding | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dizzy | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fainted | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Inflammation | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Nausea | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hematoma | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Other Adverse Event | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |